Latest Partnerships News

Vection Technologies has reported its third straight quarter of positive operating cash flow, driven by a $30 million Defence order book and a surge in AI contracts worth $4 million across multiple sectors.

CurveBeam AI reported stable device orders but faces regulatory delays for FDA and China clearances, while securing a A$4 million investment from WEGO Orthopaedics and advancing clinical collaborations with robotic surgery systems.

Gentrack’s airport technology arm Veovo is acquiring Dubai Technology Partners for US$10 million, boosting its AI portfolio and regional presence in the Middle East.

Talga Group reported record anode production at its EVA plant and significant progress on its 5,000tpa Vittangi anode plant FEED study, alongside strategic partnerships and exploration breakthroughs.

H3 Energy confirms promising gas flow potential at Warro and appoints LAB Energy to secure partners for Alinya, while facing a critical cash crunch.

Brockman Mining Limited continues to develop its Marillana and Ophthalmia iron ore projects through joint ventures, progressing infrastructure plans at Port Hedland while maintaining a modest cash position and strong financing facilities.

OMG Group posted a 44% increase in Q3 FY26 net sales, hitting a $6 million annual turnover milestone, while launching a dual matcha brand platform and securing national Woolworths distribution for new oat milk protein flavours.

Condor Energy has advanced its offshore Peru exploration with a new Raya West prospect, lifting its unrisked prospective resources above 3.3 billion barrels, while moving to 100% ownership of TEA 86 to streamline licence conversion and partnerships.

Altech Batteries has won conditional approval for a €46.11 million German government grant supporting its CERENERGY® Sodium-Chloride Solid-State battery project, while shifting its Silumina AnodesTM R&D operations to Germany to enhance efficiency and cut costs.

Orbital Corporation advances its UAV engine production and hybrid propulsion technology while managing a $0.5 million net cash outflow in Q1 2026, supported by a $43 million business pipeline and new international contracts.

Starpharma has confirmed FDA alignment for its DEP® HER2 first-in-human phase 1 trial, with preparations underway for a mid-2026 start. The biotech also progressed strategic partnerships, published promising data with Genentech, and reported a $14.1 million cash balance alongside rising Viraleze™ sales.

Green Technology Metals (ASX: GT1) sharpens focus on its Seymour Lithium Project amid a lithium price rebound, key permitting progress, and extended C$100 million financing interest from Export Development Canada.